NCT03067194

The Study to Evaluate Efficacy and Safety of Celecoxib Capsule in Hand Osteoarthritis Patients

Open-label, Multicenter, Randomized Study to Assess the Efficacy and Safety of Celecoxib 200mg Capsule QD and Celecoxib 100mg BID in Hand Osteoarthritis Patients

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 117 (actual)
• Sponsor: Chong Kun Dang Pharmaceutical · Industry
• Sex: All
• Age: 19 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to evaluate efficacy and safety of Celecoxib capsule in hand osteoarthritis patients.

Detailed description

This is a six-weeks, open-label, multi-center, randomized study. Patients take Celecoxib 200mg capsule once a day or Celecoxib 100mg capsules twice per day. If patients do not tolerate the pain, they are able to take Acetaminophen as a rescue medication during 6 weeks.

Conditions

• Osteoarthritis Hand

Interventions

Type	Name	Description
DRUG	Celecoxib 100 MG	Celecoxib 100mg, Oral, BID(twice per day), During 6 weeks
DRUG	Celecoxib 200mg	Celecoxib 200mg, Oral, QD(once daily), During 6 weeks

Timeline

• Start date: 2016-12-27
• Primary completion: 2017-07-10
• Completion: 2018-11-20
• First posted: 2017-03-01
• Last updated: 2020-01-30

Locations

1 site across 1 country: South Korea